Evaluating liver resection outcomes post Y90 TARE with personalized dosimetry in intermediate or advanced hepatocellular carcinoma: a focus on surgical and biliary complications
This study highlights the importance of timing between TARE and surgery, suggesting a waiting period of at least 6 months. Such timing not only enhances the radiation effects of TARE but also optimizes both future liver remnant growth and patient selection.
Authors
- Boris Guiu (ORCID: https://orcid.org/0000-0003-1277-3054)
- Carole Allimant
- Valentina Schembri
- Mohamad Azhar Meerun (ORCID: https://orcid.org/0000-0002-2887-7344)
- Fabrizio Panaro (ORCID: https://orcid.org/0000-0001-8200-4969)
- Margaux Hermida
- Denis Mariano‐Goulart (ORCID: https://orcid.org/0000-0001-7044-2961)
- Christine Latry-Kuhn
Institutions
- Inserm (FR)
- Université de Montpellier (FR)
- Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Institut Universitaire de Recherche Clinique (FR)
- Hôpital Saint Eloi (FR)
Publication Details
- Journal
- HepatoBiliary Surgery and Nutrition
- Published
- 2024-11-21
- DOI
- https://doi.org/10.21037/hbsn-24-151
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37